Modulation of actin mRNAs in cultured vascular cells by matrix components and TGF-beta 1.
Alpha-smooth muscle actin is currently considered a marker of smooth muscle cell differentiation. However, during various physiologic and pathologic conditions, it can be expressed, sometimes only transiently, in a variety of other cell types, such as cardiac and skeletal muscle cells, as well as in nonmuscle cells. In this report, the expression of actin mRNAs in cultured rat capillary endothelial cells (RFCs) and aortic smooth muscle cells (SMCs) has been studied by Northern hybridization in two-dimensional cultures seeded on individual extracellular matrix proteins and in three-dimensional type I collagen gels. In two-dimensional cultures, in addition to cytoplasmic actin mRNAs which are normally found in endothelial cell populations, RFCs expressed alpha-smooth muscle (SM) actin mRNA at low levels. alpha-SM actin mRNA expression is dramatically enhanced by TGF-beta 1. In addition, double immunofluorescence staining with anti-vWF and anti-alpha-SM-1 (a monoclonal antibody to alpha-SM actin) shows that RFCs co-express the two proteins. In three dimensional cultures, RFCs still expressed vWF, but lost staining for alpha-SM actin, whereas alpha-SM actin mRNA became barely detectable. In contrast to two-dimensional cultures, the addition of TGF-beta 1 to the culture media did not enhance alpha-SM actin mRNA in three-dimensional cultures, whereas it induced rapid capillary tube formation. Actin mRNA expression was modulated in SMCs by extracellular matrix components and TGF-beta 1 with a pattern very different from that of RFCs. Namely, the comparison of RFCs with other cell types such as bovine aortic endothelial cells shows that co-expression of endothelial and smooth muscle cell markers is very unique to RFCs and occurs only in particular culture conditions. This could be related to the capacity of these microvascular endothelial cells to modulate their phenotype in physiologic and pathologic conditions, particularly during angiogenesis, and could reflect different embryologic origins for endothelial cell populations.
Kocher
O
O
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510.
Madri
J A
JA
D000199:Actins / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D000818:Animals; D000906:Antibodies / Q000276:immunology; D002460:Cell Line; D002478:Cells, Cultured; D003094:Collagen / Q000032:analysis / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism* / Q000473:pathology; D005109:Extracellular Matrix / Q000032:analysis; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism / Q000473:pathology; D005353:Fibronectins / Q000032:analysis / Q000494:pharmacology*; D005455:Fluorescent Antibody Technique; D005786:Gene Expression Regulation; D007797:Laminin / Q000032:analysis / Q000494:pharmacology*; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000378:metabolism / Q000473:pathology; D012333:RNA, Messenger / Q000187:drug effects* / Q000235:genetics; D051381:Rats; D015291:Transforming Growth Factors / Q000494:pharmacology*
D000199:Actins; D000906:Antibodies; D005353:Fibronectins; D007797:Laminin; D012333:RNA, Messenger; D015291:Transforming Growth Factors; D003094:Collagen